$45.43
0.68 (+1.52%)
GlaxoSmithKline plc (ADR) (NYSE:GSK)
CAPS Rating:
The Company is a global healthcare group which is engaged in the creation and discovery, development, manufacture and marketing of pharmaceutical products, including vaccines, over-the-counter medicines and health-related consumer products.
RSS Headlines
Fool UK
Recs
Good Company. Good Dividend. They make a lot of staples. What else can ask for right now.